- Clear All
- Remove theJAVMA Newsfilter JAVMA News
- Remove thePolicyfilter Policy
- Remove theBasic pagefilter Basic page
- Remove thePreventive medicinefilter Preventive medicine
- Remove theToxicologyfilter Toxicology
- Remove the2012filter 2012
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove theProduction medicinefilter Production medicine
- Remove theBiosecurityfilter Biosecurity
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
New policy addresses FMD outbreak scenario
As a proactive move, the AVMA Executive Board approved a new policy during its Nov. 15-17, 2012, meeting that will be sent to the federal government…
Antimicrobial use and resistance: FAQs for pet owners
AVMA's antimicrobial FAQs provide science-based information to help you make educated decisions about the use of antibiotics and other antimicrobial…
JAVMA news
FDA cancels 1977 drug withdrawal bids
This past December, federal drug authorities canceled a 34-year-old proposal to withdraw approvals for some antimicrobial uses in feed.
JAVMA news
FDA denies petitions to restrict livestock drug use
Federal drug authorities denied in November 2011 two petitions to rescind approvals for many antimicrobial uses in livestock.